https://asia.nikkei.com/Business/Pharmaceuticals/Eisai-eyes-2024-launch-of-trials-for-new-Alzheimer-s-drug
Looks like there is a bit of work to be had from our 6.8% shareholder in the coming periods.
https://asia.nikkei.com/Business/Pharmaceuticals/Eisai-eyes-2024-...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.005(0.52%) |
Mkt cap ! $167.5M | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 97.0¢ | 96.5¢ | $26.40K | 27.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14972 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 535 | 3 |
View Market Depth
| Last trade - 10.39am 12/11/2024 (20 minute delay) ? |
| CGS (ASX) Chart |